The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Arsenic and Cardiovascular Disease
Open accessAbstract
Chronic arsenic exposure is a worldwide health problem. Although arsenic-induced cancer has been widely studied, comparatively little attention has been paid to arsenic-induced vascular disease. Epidemiological studies have shown that chronic arsenic exposure is associated with increased morbidity and mortality from cardiovascular disease. In addition, studies suggest that susceptibility to arsenic-induced vascular disease may be modified by nutritional factors in addition to genetic factors. Recently, animal models for arsenic-induced atherosclerosis and liver sinusoidal endothelial cell dysfunction have been developed. Initial studies in these models show that arsenic exposure accelerates and exacerbates atherosclerosis in apolipoprotein E-knockout mice. Microarray studies of liver mRNA and micro-RNA abundance in mice exposed in utero suggest that a permanent state of stress is induced by the arsenic exposure. Furthermore, the livers of the arsenic-exposed mice have activated pathways involved in immune responses suggesting a pro-hyperinflammatory state. Arsenic exposure of mice after weaning shows a clear dose-response in the extent of disease exacerbation. In addition, increased inflammation in arterial wall is evident. In response to arsenic-stimulated oxidative signaling, liver sinusoidal endothelium differentiates into a continuous endothelium that limits nutrient exchange and waste elimination. Data suggest that nicotinamide adenine dinucleotide phosphate oxidase-derived superoxide or its derivatives are essential second messengers in the signaling pathway for arsenic-stimulated vessel remodeling. The recent findings provide future directions for research into the cardiovascular effects of arsenic exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“Circulating markers of systemic inflammation and endothelial dysfunction such as soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1) are predictive for CVD (Blankenberg et al., 2001; Hwang et al., 1997; Ridker et al., 1998, 2000).”
Hayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083491 · Cited by 3,464
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Hayes, J. D., & McLellan, L. I. (1999) · Free Radical Research · doi:10.1080/10715769900300851 · Cited by 1,525
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Hwang, S.-J., Ballantyne, C. M., Sharrett, A. R., Smith, L. C., Davis, C. E., Gotto, A. M., & Boerwinkle, E. (1997) · Circulation · doi:10.1161/01.cir.96.12.4219 · Cited by 1,344
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304 · cited 1×
“inflammatory responses, and endothelial nitric oxide homeostasis (Simeonova and Luster, 2004), which play an important role in maintaining vascular tone (Willerson and Ridker, 2004).”
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229 · cited 1×
“Circulating markers of systemic inflammation and endothelial dysfunction such as soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1) are predictive for CVD (Blankenberg et al., 2001; Hwang et al., 1997; Ridker et al., 1998, 2000).”
Cited by
Prevalence of exposure of heavy metals and their impact on health consequences
Rehman, K., Fatima, F., Waheed, I., & Akash, M. S. H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26234 · Cited by 1,576
Arsenic: toxicity, oxidative stress and human disease
Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., Rhodes, C. J., & Valko, M. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1649 · Cited by 1,431
Naujokas, M. F., Anderson, B., Ahsan, H., Aposhian, H. V., Graziano, J. H., Thompson, C., & Suk, W. A. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205875 · Cited by 1,372
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Arsenic and human health effects: A review
Mohammed Abdul, K. S., Jayasinghe, S. S., Chandana, E. P. S., Jayasumana, C., & De Silva, P. M. C. S. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.09.016 · Cited by 907
Arsenic-induced oxidative stress and its reversibility
Flora, S. J. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.008 · Cited by 824
Environmental factors in cardiovascular disease
Cosselman, K. E., Navas-Acien, A., & Kaufman, J. D. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.152 · Cited by 613
Earth Abides Arsenic Biotransformations
Zhu, Y.-G., Yoshinaga, M., Zhao, F.-J., & Rosen, B. P. (2014) · Annual Review of Earth and Planetary Sciences · doi:10.1146/annurev-earth-060313-054942 · Cited by 550
“Arsenic exposure is related to cardiovascular disease (States et al. 2009, Tseng et al. 2003), diabetes (Drobná et al. 2012, Tseng et al. 2002), peripheral neuropathy (Mukherjee et al. 2003) and peripheral vascular (blackfoot) disease (Tseng et al. 1995).”
BackgroundArsenic Exposure and Cardiovascular Disease:An Updated Systematic Review
Moon, K., Guallar, E., & Navas-Acien, A. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0280-x · Cited by 378
Heavy Metal Exposure and Cardiovascular Disease
Pan, Z., Gong, T., & Liang, P. (2024) · Circulation Research · doi:10.1161/circresaha.123.323617 · Cited by 306
Moon, K. A., Guallar, E., Umans, J. G., Devereux, R. B., Best, L. G., Francesconi, K. A., Goessler, W., Pollak, J., Silbergeld, E. K., Howard, B. V., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-10-201311190-00719 · Cited by 272
Lamas, G. A., Bhatnagar, A., Jones, M. R., Mann, K. K., Nasir, K., Tellez‐Plaza, M., Ujueta, F., Navas‐Acien, A., & the American Heart Association Council on Epidemiology and Prevention; Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Council on the Kidney in Cardiovascular Disease (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029852 · Cited by 238
Wang, L., Kou, M.-C., Weng, C.-Y., Hu, L.-W., Wang, Y.-J., & Wu, M.-J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0845-z · Cited by 98
Metadata
- Authors
- States, J. C., Srivastava, S., Chen, Y., & Barchowsky, A.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11-17
- Volume
- 107
- Issue
- 2
- Pages
- 312-323
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2168739412
- Cited by
- 350
- References
- 121
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.